Detalles de la búsqueda
1.
A phase 2, open-label study of brentuximab vedotin in patients with CD30-expressing solid tumors.
Invest New Drugs
; 37(4): 738-747, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30993587
2.
Phase I study of the combination of crizotinib (as a MET inhibitor) and dasatinib (as a c-SRC inhibitor) in patients with advanced cancer.
Invest New Drugs
; 36(3): 416-423, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29047029
3.
A phase I, open-label, two-stage study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral AKT inhibitor GSK2141795 in patients with solid tumors.
Invest New Drugs
; 36(6): 1016-1025, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29611022
4.
Outcomes of patients ≥65 years old with advanced cancer treated on phase I trials at MD ANDERSON CANCER CENTER.
Int J Cancer
; 140(1): 208-215, 2017 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27599876
5.
Phase I Dose-Escalation Study of Pilaralisib (SAR245408, XL147) in Combination with Paclitaxel and Carboplatin in Patients with Solid Tumors.
Oncologist
; 22(4): 377-e37, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28275119
6.
Phase 1 study of APTO-253 HCl, an inducer of KLF4, in patients with advanced or metastatic solid tumors.
Invest New Drugs
; 33(5): 1086-92, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26268924
7.
Dual antiangiogenic inhibition: a phase I dose escalation and expansion trial targeting VEGF-A and VEGFR in patients with advanced solid tumors.
Invest New Drugs
; 33(1): 215-24, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25363205
8.
A phase I trial of combination trastuzumab, lapatinib, and bevacizumab in patients with advanced cancer.
Invest New Drugs
; 33(1): 177-86, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25323060
9.
Dose-finding study of hepatic arterial infusion of irinotecan-based treatment in patients with advanced cancers metastatic to the liver.
Invest New Drugs
; 33(4): 911-20, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25990659
10.
Xilonix, a novel true human antibody targeting the inflammatory cytokine interleukin-1 alpha, in non-small cell lung cancer.
Invest New Drugs
; 33(3): 621-31, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25822109
11.
Phase I combination of pazopanib and everolimus in PIK3CA mutation positive/PTEN loss patients with advanced solid tumors refractory to standard therapy.
Invest New Drugs
; 33(3): 700-9, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25902899
12.
Multiple gene aberrations and breast cancer: lessons from super-responders.
BMC Cancer
; 15: 442, 2015 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-26021831
13.
Next generation sequencing of exceptional responders with BRAF-mutant melanoma: implications for sensitivity and resistance.
BMC Cancer
; 15: 61, 2015 Feb 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-25886620
14.
Olanzapine for cachexia in patients with advanced cancer: an exploratory study of effects on weight and metabolic cytokines.
Support Care Cancer
; 23(9): 2649-54, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25680763
15.
MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study.
Lancet Oncol
; 15(6): 656-66, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24746841
16.
Dual inhibition of the vascular endothelial growth factor pathway: a phase 1 trial evaluating bevacizumab and AZD2171 (cediranib) in patients with advanced solid tumors.
Cancer
; 120(14): 2164-73, 2014 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24752867
17.
Phase I dose-escalating study of TAS-106 in combination with carboplatin in patients with solid tumors.
Invest New Drugs
; 32(1): 154-9, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23609829
18.
Exploratory study of carboplatin plus the copper-lowering agent trientine in patients with advanced malignancies.
Invest New Drugs
; 32(3): 465-72, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24306314
19.
Phase I clinical trial of lenalidomide in combination with sorafenib in patients with advanced cancer.
Invest New Drugs
; 32(2): 279-86, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23756764
20.
Evaluation of a novel blood pressure scoring method and its association with clinical response in cancer patients treated with anti-vascular endothelial growth factor therapy.
Invest New Drugs
; 32(4): 717-22, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24764123